{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:31:31Z","timestamp":1790155891727,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["10\/014"],"award-info":[{"award-number":["10\/014"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.antiviral.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T14:00:27Z","timestamp":1493128827000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-9101","authenticated-orcid":false,"given":"Fabrizio","family":"Pertusati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmiyah","family":"Albadry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.04.013_bib1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.bmc.2004.11.057","article-title":"Synthesis and antiviral activity of novel acyclic nucleosides in the 5-alkynyl- and 6-alkylfuro[2,3-d]pyrimidine series","volume":"13","author":"Amblard","year":"2005","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.013_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tet.2004.11.019","article-title":"Efficient synthesis of various acycloalkenyl derivatives of pyrimidine using cross-metathesis and Pd(0) methodologies","volume":"61","author":"Amblard","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.antiviral.2017.04.013_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/AAC.37.2.332","article-title":"Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in\u00a0vitro and in\u00a0vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine","volume":"37","author":"Balzarini","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.04.013_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0040-4039(00)70495-3","article-title":"The reaction of \u03b1-bromoketones with triphenylphosphine - I","volume":"3","author":"Borowitz","year":"1962","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.antiviral.2017.04.013_bib5","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1128\/AAC.01152-15","article-title":"In\u00a0vitro virology profile of tenofovir alafenamide, a novel oral prodrug of tenofovir with improved antiviral activity compared to that of tenofovir disoproxil fumarate","volume":"59","author":"Callebaut","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.04.013_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A\u00a0novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.04.013_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bcp.2006.09.014","article-title":"Acyclic nucleoside phosphonates: past, present and future: bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge","volume":"73","author":"De Clercq","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2017.04.013_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.antiviral.2017.04.013_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"De Clercq","year":"1987","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.04.013_bib10","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1021\/jm9007856","article-title":"The application of phosphoramidate ProTide technology to acyclovir confers anti-HIV inhibition","volume":"52","author":"Derudas","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.013_bib11","series-title":"Substituent Constants for Correlation Analysis in Chemistry and Biology","author":"Hansch","year":"1979"},{"key":"10.1016\/j.antiviral.2017.04.013_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0040-4039(00)76934-6","article-title":"\u00dcber die einwirkung von terti\u00e4ren phosphinen auf \u03b1-halogencarbonylverbindungen (modellversuche zur perkow-reaktion)","volume":"3","author":"Hoffmann","year":"1962","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.antiviral.2017.04.013_bib13","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1016\/j.ejmech.2011.05.040","article-title":"A\u00a0novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities","volume":"46","author":"Jansa","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.013_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2013.09.047","article-title":"Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides","volume":"70","author":"McGuigan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.013_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2013.09.047","article-title":"Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides","volume":"70","author":"McGuigan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.013_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1081\/NCN-51913","article-title":"Concise synthesis and antiviral activity of novel unsaturated acyclic pyrimidine nucleosides","volume":"24","author":"Oh","year":"2005","journal-title":"Nucleos. Nucleot. Nucl."},{"key":"10.1016\/j.antiviral.2017.04.013_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2014.03.051","article-title":"PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer","volume":"78","author":"Pertusati","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.013_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3851\/IMP2012","article-title":"Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy","volume":"22","author":"Pertusati","year":"2012","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2017.04.013_bib20","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/jm300074y","article-title":"Novel phosphoramidate prodrugs of N-Acetyl-(d)-Glucosamine with antidegenerative activity on bovine and human cartilage explants","volume":"55","author":"Serpi","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.04.013_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/22113525113119990106","article-title":"Unsaturation: an important structural feature to nucleosides' antiviral activity","volume":"12","author":"Stella","year":"2014","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.antiviral.2017.04.013_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm1011462","article-title":"Novel antiviral C5-Substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates","volume":"54","author":"Topalis","year":"2011","journal-title":"J.\u00a0Med. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T06:50:55Z","timestamp":1535871055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217300657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":21,"alternative-id":["S0166354217300657"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.04.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}